News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingView Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Wall Street Zen has upgraded Inovio Pharmaceuticals (NASDAQ:INO) from a "Sell" to a "Hold" rating, though overall analyst opinions remain mixed, with MarketBeat reporting a "Moderate Buy" consensus. The company recently exceeded earnings estimates, reporting a quarterly EPS of negative $0.07 against an expected …
Red Violet Inc (RDVT) shares fell 5.4% to $69.65, yet remain significantly overvalued according to GuruFocus's GF Value of $47.91. The company has a GF Score of 68/100, indicating above-average quality but with concerns regarding its valuation (3/10) and insider selling activity. Investors are …
This article details an SEC Form 144 filing by Artivion, Inc. (AORT) on August 14, 2026, which indicates a proposed sale of 715 shares of common stock acquired through restricted stock vesting. The filing was accepted by the SEC at 3:59 PM on the …
Nomura Asset Management International Inc. and Nomura Investment Management Business Trust have reported a combined 6.5% beneficial ownership in Artivion, Inc., totaling 3,184,974 shares of common stock. This filing, a Schedule 13G/A, indicates shared voting and dispositive power over these shares, calculated based on …
Inovio Pharmaceuticals Inc. (INO) shares surged 21.10% to $1.09 on Friday, outperforming the broader market as the NASDAQ Composite Index and Dow Jones Industrial Average both experienced declines. This marked the fifth consecutive day of gains for Inovio's stock, despite a generally rough trading …
Sharemaestro market context Price below Trend Line 52 weeks -64.8% · Next-week setup negative 34.0%Navios Maritime Partners (NMM) reported strong Q1 2024 earnings, beating analyst expectations with an actual EPS of $2.32 against a consensus of $2.01, and revenue of $318.56 million against an expected $283.59 million. This marks a 2.92% year-over-year revenue growth. The company has also …
Red Violet (RDVT) reported strong Q2 2026 results with $26.72 million in sales and $4.96 million in net income, alongside a $100 million equity raise for M&A. The company plans to use this capital for strategic acquisitions to expand its identity-analytics platform. This move …
Zacks Research has upgraded Inovio Pharmaceuticals (NASDAQ:INO) to a "strong-buy" rating. This upgrade comes as the company reported a quarterly loss of $0.07 per share, beating analyst expectations, and anticipates an FDA decision for its key product INO-3107 by October 30, 2026. The company …
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chairman, President, and Chief Executive Officer - Pat MackinExecutive Vice President, Chief Operating Officer and Chief Financial Officer - Lance Berry TAKEAWAYS Revenue -- $125.8 million, up 9% …
This article provides the Q2 2024 earnings report for Navios Maritime Partners (NMM), detailing their actual EPS of $3.06 which beat the consensus of $2.84, and actual revenue of $342.16M, exceeding the expected $312.39M. It includes earnings announcement details, a link to the earnings …
This article provides the options chain for Indivior Pharmaceuticals, Inc. (INDV), listing both call and put options with their respective strike prices, last trade dates, prices, and other relevant data. It includes current stock performance and related pharmaceutical tickers.
Red Violet (RDVT) stock has reached an all-time high of $72.97, reflecting a significant 65.96% increase over the past year. The company reported strong Q2 2026 financial results, with adjusted earnings of $0.50 per share and revenue of $26.72 million, surpassing analyst expectations. Despite …
Red Violet, Inc. (NASDAQ: RDVT) announced it will present at the Midwest IDEAS Investor Conference in Chicago on August 26-27, 2026. Camilo Ramirez, Senior Vice President of Finance and Investor Relations, will host investor meetings and present on August 27, 2026. Red Violet is …
Red Violet (NASDAQ: RDVT) announced it will present at the Midwest IDEAS Investor Conference in Chicago from August 26-27, 2026. Camilo Ramirez, Senior Vice President of Finance and Investor Relations, will deliver the company's presentation and host investor meetings on August 27, 2026. The …
Indivior Plc (INDV) has been actively discussed in news concerning its proposed merger with Supernus Pharmaceuticals, Inc. The merger aims to create a CNS-focused biopharmaceutical leader with potential revenues of $2.2 billion. Various investor rights law firms are investigating the adequacy of the price …
Seven analysts have issued a consensus "Hold" rating for Inovio Pharmaceuticals (NASDAQ:INO), with an average 12-month price target of $3.25. The company recently reported a quarterly loss of $0.07 per share, outperforming analyst expectations, while institutional investors own approximately 26.79% of its stock. Shares …
Angeliki Frangou, an insider at Navios Maritime Partners (NYSE:NMM), recently purchased an additional 1,050 shares of the company's stock, valued at approximately $83,045. This transaction is part of a series of recent buys, increasing her total holdings to 4.79 million shares. The company has …
Angeliki Frangou, an insider at Navios Maritime Partners (NYSE:NMM), recently purchased 1,062 shares of the company's stock for $79.16 per share, increasing her total holdings to over 4.79 million shares. This latest transaction continues a series of insider buys over several trading sessions. The …
Angeliki Frangou, CEO and Chairwoman of Navios Maritime Partners L.P. (NMM), reported purchasing 3,169 common units of NMM between August 10-12, 2026. These open-market purchases were made indirectly through Raymar Investments S.A. under a pre-arranged Rule 10b5-1 trading plan. The purchases occurred at weighted …
Inovio (INO) discussed its Q2 2026 financial results and provided an update on its lead candidate, INO-3107, which has a PDUFA date of October 30, 2026. The company highlighted progress in regulatory reviews, commercial launch preparations, and positive Phase III results for VGX-3100 from …
Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Director of Communications - Jennie WillsonPresident and Chief Executive Officer - Dr. Jacqueline E. SheaChief Medical Officer - Dr. Michael SumnerChief Commercial Officer - Steven EggeChief Financial Officer …
Sharemaestro market context Price below Trend Line 52 weeks -64.8% · Next-week setup negative 34.0%Red Violet Inc (RDVT) shares fell 3.3% to $68.82. The stock is considered "Significantly Overvalued" by GuruFocus, with its current price 43.0% above the GF Value™ estimate of $48.11. Despite a strong financial strength rating of 8/10 and momentum of 9/10, the valuation rank …
Jean F. Holloway, SVP at Artivion Inc. (NASDAQ:AORT), sold 977 shares for $27,834 at $28.49 per share. This transaction occurred after the stock saw a 9.4% gain over the past week, and Holloway now directly holds 184,118 shares. The company recently reported strong Q2 …
Jean Holloway, SVP of Artivion (NYSE:AORT), sold 977 shares of the company's stock for a total of $27,834.73, reducing her direct ownership to 184,118 shares. This transaction occurred as Artivion reported strong quarterly earnings, exceeding revenue estimates, and maintains a "Moderate Buy" consensus rating …
INOVIO announced its second-quarter 2026 financial results, highlighting the advancement of the FDA's review of its BLA for INO-3107 for Recurrent Respiratory Papillomatosis with a target PDUFA date of October 30, 2026. The company also reported positive Phase 3 results for VGX-3100 in cervical …
Artivion (AORT) stock rose by 5.5% following FDA approval for its AMDS hybrid prosthesis and the reaffirmation of its 2026 revenue guidance. The company reported increased revenue but a shift to a net loss in Q2 2026. This approval for AMDS is considered a …
Search by ticker symbol or company name and select a result to open its chart.